A citation-based method for searching scientific literature

Elías Cuesta-Llavona, Guillermo M Albaiceta, Marta García-Clemente, Israel D Duarte-Herrera, Laura Amado-Rodríguez, Tamara Hermida-Valverde, Ana I Enríquez-Rodriguez, Cristina Hernández-González, Santiago Melón, Marta E Alvarez-Argüelles, José A Boga, Susana Rojo-Alba, Daniel Vázquez-Coto, Juan Gómez, Eliecer Coto. Curr Res Virol Sci 2021
Times Cited: 8







List of co-cited articles
48 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Interferon-induced transmembrane protein-3 genetic variant rs12252 is associated with COVID-19 mortality.
Jahad Alghamdi, Manal Alaamery, Tlili Barhoumi, Mamoon Rashid, Hala Alajmi, Nasser Aljasser, Yaseen Alhendi, Hind Alkhalaf, Hanadi Alqahtani, Omer Algablan,[...]. Genomics 2021
12
62

The Interferon-induced transmembrane protein 3 gene (IFITM3) rs12252 C variant is associated with COVID-19.
Juan Gómez, Guillermo M Albaiceta, Elías Cuesta-Llavona, Marta García-Clemente, Carlos López-Larrea, Laura Amado-Rodríguez, Inés López-Alonso, Santiago Melón, Marta E Alvarez-Argüelles, Helena Gil-Peña,[...]. Cytokine 2021
34
62

IFITM3 restricts the morbidity and mortality associated with influenza.
Aaron R Everitt, Simon Clare, Thomas Pertel, Sinu P John, Rachael S Wash, Sarah E Smith, Christopher R Chin, Eric M Feeley, Jennifer S Sims, David J Adams,[...]. Nature 2012
517
50

Genetic mechanisms of critical illness in COVID-19.
Erola Pairo-Castineira, Sara Clohisey, Lucija Klaric, Andrew D Bretherick, Konrad Rawlik, Dorota Pasko, Susan Walker, Nick Parkinson, Max Head Fourman, Clark D Russell,[...]. Nature 2021
487
50

Interferon-Induced Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease 2019.
Yonghong Zhang, Ling Qin, Yan Zhao, Ping Zhang, Bin Xu, Kang Li, Lianchun Liang, Chi Zhang, Yanchao Dai, Yingmei Feng,[...]. J Infect Dis 2020
80
50

Opposing activities of IFITM proteins in SARS-CoV-2 infection.
Guoli Shi, Adam D Kenney, Elena Kudryashova, Ashley Zani, Lizhi Zhang, Kin Kui Lai, Luanne Hall-Stoodley, Richard T Robinson, Dmitri S Kudryashov, Alex A Compton,[...]. EMBO J 2021
72
37

IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro.
Caterina Prelli Bozzo, Rayhane Nchioua, Meta Volcic, Lennart Koepke, Jana Krüger, Desiree Schütz, Sandra Heller, Christina M Stürzel, Dorota Kmiec, Carina Conzelmann,[...]. Nat Commun 2021
35
37

SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans.
E Kaitlynn Allen, Adrienne G Randolph, Tushar Bhangale, Pranay Dogra, Maikke Ohlson, Christine M Oshansky, Anthony E Zamora, John P Shannon, David Finkelstein, Amy Dressen,[...]. Nat Med 2017
112
37


Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.
Qian Zhang, Paul Bastard, Zhiyong Liu, Jérémie Le Pen, Marcela Moncada-Velez, Jie Chen, Masato Ogishi, Ira K D Sabli, Stephanie Hodeib, Cecilia Korol,[...]. Science 2020
37

Autoantibodies against type I IFNs in patients with life-threatening COVID-19.
Paul Bastard, Lindsey B Rosen, Qian Zhang, Eleftherios Michailidis, Hans-Heinrich Hoffmann, Yu Zhang, Karim Dorgham, Quentin Philippot, Jérémie Rosain, Vivien Béziat,[...]. Science 2020
37

Cell entry mechanisms of SARS-CoV-2.
Jian Shang, Yushun Wan, Chuming Luo, Gang Ye, Qibin Geng, Ashley Auerbach, Fang Li. Proc Natl Acad Sci U S A 2020
37

Systematic review of host genetic association with Covid-19 prognosis and susceptibility: What have we learned in 2020?
João Locke Ferreira de Araújo, Diego Menezes, Julia Maria Saraiva-Duarte, Luciana de Lima Ferreira, Renato Santana de Aguiar, Renan Pedra de Souza. Rev Med Virol 2022
7
42

The influence of IFITM3 polymorphisms on susceptibility to SARS-CoV-2 infection and severity of COVID-19.
Kristina Schönfelder, Katharina Breuckmann, Carina Elsner, Ulf Dittmer, David Fistera, Frank Herbstreit, Joachim Risse, Karsten Schmidt, Sivagurunathan Sutharsan, Christian Taube,[...]. Cytokine 2021
16
37

Lessons in self-defence: inhibition of virus entry by intrinsic immunity.
Saliha Majdoul, Alex A Compton. Nat Rev Immunol 2022
9
25

Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2.
Guoli Shi, Abhilash I Chiramel, Saliha Majdoul, Kin Kui Lai, Tirhas Dempsey, Adam Kenney, Ashley Zani, Adrian Eddy, Lizhi Zhang, Paul A Beare,[...]. bioRxiv 2022
4
50

Syncytia formation by SARS-CoV-2-infected cells.
Julian Buchrieser, Jérémy Dufloo, Mathieu Hubert, Blandine Monel, Delphine Planas, Maaran Michael Rajah, Cyril Planchais, Françoise Porrot, Florence Guivel-Benhassine, Sylvie Van der Werf,[...]. EMBO J 2020
154
25

Interferon induction of IFITM proteins promotes infection by human coronavirus OC43.
Xuesen Zhao, Fang Guo, Fei Liu, Andrea Cuconati, Jinhong Chang, Timothy M Block, Ju-Tao Guo. Proc Natl Acad Sci U S A 2014
109
25

IFITM3 requires an amphipathic helix for antiviral activity.
Nicholas M Chesarino, Alex A Compton, Temet M McMichael, Adam D Kenney, Lizhi Zhang, Victoria Soewarna, Matthew Davis, Olivier Schwartz, Jacob S Yount. EMBO Rep 2017
57
25

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S Schiergens, Georg Herrler, Nai-Huei Wu, Andreas Nitsche,[...]. Cell 2020
25

Genomewide Association Study of Severe Covid-19 with Respiratory Failure.
David Ellinghaus, Frauke Degenhardt, Luis Bujanda, Maria Buti, Agustín Albillos, Pietro Invernizzi, Javier Fernández, Daniele Prati, Guido Baselli, Rosanna Asselta,[...]. N Engl J Med 2020
919
25

IFITM proteins restrict viral membrane hemifusion.
Kun Li, Ruben M Markosyan, Yi-Min Zheng, Ottavia Golfetto, Brittani Bungart, Minghua Li, Shilei Ding, Yuxian He, Chen Liang, James C Lee,[...]. PLoS Pathog 2013
234
25

Identification of an endocytic signal essential for the antiviral action of IFITM3.
Rui Jia, Fengwen Xu, Jin Qian, Yunfang Yao, Chunhui Miao, Yi-Min Zheng, Shan-Lu Liu, Fei Guo, Yunqi Geng, Wentao Qiao,[...]. Cell Microbiol 2014
88
25

IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion.
Tanay M Desai, Mariana Marin, Christopher R Chin, George Savidis, Abraham L Brass, Gregory B Melikyan. PLoS Pathog 2014
191
25

IFITM3 directly engages and shuttles incoming virus particles to lysosomes.
Jennifer S Spence, Ruina He, Hans-Heinrich Hoffmann, Tandrila Das, Emmanuelle Thinon, Charles M Rice, Tao Peng, Kartik Chandran, Howard C Hang. Nat Chem Biol 2019
109
25

The broad-spectrum antiviral functions of IFIT and IFITM proteins.
Michael S Diamond, Michael Farzan. Nat Rev Immunol 2013
473
25

The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets.
Thomas P Peacock, Daniel H Goldhill, Jie Zhou, Laury Baillon, Rebecca Frise, Olivia C Swann, Ruthiran Kugathasan, Rebecca Penn, Jonathan C Brown, Raul Y Sanchez-David,[...]. Nat Microbiol 2021
186
25

Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus.
I-Chueh Huang, Charles C Bailey, Jessica L Weyer, Sheli R Radoshitzky, Michelle M Becker, Jessica J Chiang, Abraham L Brass, Asim A Ahmed, Xiaoli Chi, Lian Dong,[...]. PLoS Pathog 2011
415
25

Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice.
Rudragouda Channappanavar, Anthony R Fehr, Rahul Vijay, Matthias Mack, Jincun Zhao, David K Meyerholz, Stanley Perlman. Cell Host Microbe 2016
892
25

IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread.
Alex A Compton, Timothée Bruel, Françoise Porrot, Adeline Mallet, Martin Sachse, Marine Euvrard, Chen Liang, Nicoletta Casartelli, Olivier Schwartz. Cell Host Microbe 2014
127
25

Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection.
Martina Severa, Roberta A Diotti, Marilena P Etna, Fabiana Rizzo, Stefano Fiore, Daniela Ricci, Marco Iannetta, Alessandro Sinigaglia, Alessandra Lodi, Nicasio Mancini,[...]. PLoS Pathog 2021
15
25

Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial.
Jordan J Feld, Christopher Kandel, Mia J Biondi, Robert A Kozak, Muhammad Atif Zahoor, Camille Lemieux, Sergio M Borgia, Andrea K Boggild, Jeff Powis, Janine McCready,[...]. Lancet Respir Med 2021
89
25

IFITM Genes, Variants, and Their Roles in the Control and Pathogenesis of Viral Infections.
Xuesen Zhao, Jiarui Li, Cheryl A Winkler, Ping An, Ju-Tao Guo. Front Microbiol 2019
65
25

Presence of Genetic Variants Among Young Men With Severe COVID-19.
Caspar I van der Made, Annet Simons, Janneke Schuurs-Hoeijmakers, Guus van den Heuvel, Tuomo Mantere, Simone Kersten, Rosanne C van Deuren, Marloes Steehouwer, Simon V van Reijmersdal, Martin Jaeger,[...]. JAMA 2020
358
25


ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19.
Birte Möhlendick, Kristina Schönfelder, Katharina Breuckmann, Carina Elsner, Nina Babel, Paul Balfanz, Edgar Dahl, Michael Dreher, David Fistera, Frank Herbstreit,[...]. Pharmacogenet Genomics 2021
17
25

ACE I/D polymorphism in Czech first-wave SARS-CoV-2-positive survivors.
Jaroslav A Hubacek, Ladislav Dusek, Ondrej Majek, Vaclav Adamek, Tereza Cervinkova, Dana Dlouha, Vera Adamkova. Clin Chim Acta 2021
9
25

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, Xiaoying Gu,[...]. Lancet 2020
25


Effect of ACE1 polymorphism rs1799752 on protein levels of ACE2, the SARS-CoV-2 entry receptor, in alveolar lung epithelium.
Merel Jacobs, Lies Lahousse, Hannelore P Van Eeckhoutte, Sara R A Wijnant, Joris R Delanghe, Guy G Brusselle, Ken R Bracke. ERJ Open Res 2021
8
25

Association of polymorphisms in tumor necrosis factors with SARS-CoV-2 infection and mortality rate: A case-control study and in silico analyses.
Milad Heidari Nia, Mohsen Rokni, Shekoufeh Mirinejad, Maryam Kargar, Sara Rahdar, Saman Sargazi, Mohammad Sarhadi, Ramin Saravani. J Med Virol 2022
8
25

ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain.
Laura Torre-Fuentes, Jorge Matías-Guiu, Laura Hernández-Lorenzo, Paloma Montero-Escribano, Vanesa Pytel, Jesús Porta-Etessam, Ulises Gómez-Pinedo, Jordi A Matías-Guiu. J Med Virol 2021
38
25

Association between angiotensinogen (AGT), angiotensin-converting enzyme (ACE) and angiotensin-II receptor 1 (AGTR1) polymorphisms and COVID-19 infection in the southeast of Iran: a preliminary case-control study.
Hamid Reza Kouhpayeh, Farhad Tabasi, Mohammad Dehvari, Mohammad Naderi, Gholamreza Bahari, Tahereh Khalili, Courtney Clark, Saeid Ghavami, Mohsen Taheri. Transl Med Commun 2021
6
33

Association between IFITM3 rs12252 polymorphism and influenza susceptibility and severity: A meta-analysis.
Suchitra S Prabhu, Trirupa Tapas Chakraborty, Nirmal Kumar, Indranil Banerjee. Gene 2018
26
25

The 'cytokine storm': molecular mechanisms and therapeutic prospects.
Rajendra Karki, Thirumala-Devi Kanneganti. Trends Immunol 2021
33
25


Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals.
Yong-Hong Zhang, Yan Zhao, Ning Li, Yan-Chun Peng, Eleni Giannoulatou, Rong-Hua Jin, Hui-Ping Yan, Hao Wu, Jin-Hua Liu, Ning Liu,[...]. Nat Commun 2013
186
25


Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis.
Bryan A Johnson, Xuping Xie, Adam L Bailey, Birte Kalveram, Kumari G Lokugamage, Antonio Muruato, Jing Zou, Xianwen Zhang, Terry Juelich, Jennifer K Smith,[...]. Nature 2021
269
12

SARS-CoV-2 Alpha, Beta, and Delta variants display enhanced Spike-mediated syncytia formation.
Maaran Michael Rajah, Mathieu Hubert, Elodie Bishop, Nell Saunders, Remy Robinot, Ludivine Grzelak, Delphine Planas, Jérémy Dufloo, Stacy Gellenoncourt, Alice Bongers,[...]. EMBO J 2021
29
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.